Home Cart Sign in  
Chemical Structure| 646502-53-6 Chemical Structure| 646502-53-6

Structure of VcMMAE
CAS No.: 646502-53-6

Chemical Structure| 646502-53-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

VcMMAE (MC-Val-Cit-PAB-MMAE) (GMP) is produced following GMP guidelines and serves as a drug-linker conjugate for ADCs.

Synonyms: mc-vc-PAB-MMAE; MC-Val-Cit-PAB-MMAE; MMAE Vc linker, MMAE antibody conjugate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of VcMMAE

CAS No. :646502-53-6
Formula : C68H105N11O15
M.W : 1316.63
SMILES Code : O=C(OCC1=CC=C(NC([C@@H](NC([C@@H](NC(CCCCCN2C(C=CC2=O)=O)=O)C(C)C)=O)CCCNC(N)=O)=O)C=C1)N([C@@H](C(C)C)C(N[C@@H](C(C)C)C(N([C@@H]([C@@H](C)CC)[C@H](OC)CC(N3[C@H]([C@H](OC)[C@@H](C)C(N[C@H](C)[C@@H](O)C4=CC=CC=C4)=O)CCC3)=O)C)=O)=O)C
Synonyms :
mc-vc-PAB-MMAE; MC-Val-Cit-PAB-MMAE; MMAE Vc linker, MMAE antibody conjugate
MDL No. :MFCD25372036
InChI Key :NLMBVBUNULOTNS-HOKPPMCLSA-N
Pubchem ID :46944733

Safety of VcMMAE

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of VcMMAE

cytoskeleton

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
KYSE520 1, 0.3, 0.1, 0.03, 0.01, 0.003, 0.001 μg/mL 48 hours To evaluate the cytotoxicity of LR004-VC-μMAE on KYSE520 cells, the results showed an IC50 value of 1.852 ± 0.617 nM. PMC6360372
A431 1, 0.3, 0.1, 0.03, 0.01, 0.003, 0.001 μg/mL 48 hours To evaluate the cytotoxicity of LR004-VC-μMAE on A431 cells, the results showed an IC50 value of 0.019 ± 0.006 nM. PMC6360372

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice L540cy Hodgkin lymphoma model Intraperitoneal injection Approximately 100 mg/kg/d Treatment started at 3 months of age and continued To evaluate the antitumor efficacy of VcMMAE in combination with chemotherapy in Hodgkin lymphoma, showing that the combination significantly improved tumor regression rates. PMC2440525
Nude mice KYSE520 xenograft model Intravenous injection 5.15 mg/kg Administered on days 1, 3, 5, 7, and 9, lasting for 12 days To evaluate the antitumor efficacy of LR004-VC-MMAE in the KYSE520 xenograft model, the results showed complete tumor regression in all mice at the 15 mg/kg dose. PMC6360372

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

0.76mL

0.15mL

0.08mL

3.80mL

0.76mL

0.38mL

7.60mL

1.52mL

0.76mL

References

 

Historical Records

Categories